ReviewCurrent oncology (Toronto, Ont.)2023

HR+/HER2- Advanced Breast Cancer Treatment in the First-Line Setting: Expert Review.

Katarzyna J Jerzak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.